03 Profile
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Diabetes
Kenneth Custer
President of Lilly's cardiometabolic health unit
Quoted in the press, across 1 topic since 22 May 2026
02 Quoted on · 1 of 29 topics
Kenneth Custer: key facts
- Kind of voice
- Sector leader
- Role
- President of Lilly's cardiometabolic health unit
- Quoted on
- Diabetes
- Press coverage
- Quoted in the press
- Most recently quoted
- 25 Sept 2026
- First quoted
- 22 May 2026
04 The signal · where Kenneth Custer sits on diabetes
Leading
One of the voices most often quoted in the press on diabetes.
Placed by press coverage on this topic only, not across all topics.
Douglas TwenefourClinicianHead of Clinical, Diabetes UKLeading
Dr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UKLeading
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)Leading
Dr Kevin FernandoClinicianGP Partner (part-time); portfolio GP, North Berwick Health CentreLeading- Giedre CepukaityteSector leaderCognitive neuroscientist at tech company ThymiaLeading
- Kenneth CusterSector leaderPresident of Lilly's cardiometabolic health unitLeading
- Bethany KellyClinicianClinical lead diabetes specialist and co-chair of the Diabetes Specialist Nurse Forum UKLeading
- Rupy AujlaClinicianMedical doctor, chef and founder of The Doctor's KitchenLeading
Showing the leading voices and those placed around Kenneth Custer · See every voice on the topic →
05 On the record · press
What Kenneth Custer has said
- fiercepharma.com
- ladbible.com
- pharmaphorum.com
- technologynetworks.com
Where Kenneth Custer has been quoted
- Lilly brings more heat to Novo with FDA nod for once-weekly insulin Onswikfiercepharma.com · 25 Sept 2026
- Lilly's rival to Novo's new Awiqli insulin gets FDA approvalpharmaphorum.com · 24 Sept 2026
- Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patientsfiercepharma.com · 28 Aug 2026
- Overweight Patients Lose Nearly 30% Body Weight in Phase 3 Retatrutide Trialtechnologynetworks.com · 10 Jun 2026
- 'Most powerful weight-loss jab ever' that outperforms Wegovy and Mounjaro shows insane resultsladbible.com · 22 May 2026
How we found the articles that name Kenneth Custer: we searched news for these terms.
- diabetes
- type 1 diabetes
- type 2 diabetes
- insulin
- diabetic
- diabetes prevention
Also searched with “diabetes” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Diabetes
Verbatim
“For over a century, Lilly has been developing insulins that transformed diabetes care for millions of people worldwide, but delays in initiating treatment and the burden of daily injections can have a real impact on patients' day-to-day experience managing type 2 diabetes.”
“Delays in initiating treatment and the burden of daily injections can have a real impact on patients' day-to-day experience managing type 2 diabetes. Onswik offers a new once-weekly basal insulin option for patients and reflects our continued commitment to deliver innovative treatment options that expand choice and provide greater flexibility in how people manage type 2 diabetes.”
“We set a higher bar by testing Mounjaro against a GLP-1 medicine with proven cardiovascular benefit, one that reflects the depth of evidence Lilly continues to build in this field.”
“By addressing weight, glycemia, and obesity-related complications together, these results highlight retatrutide's potential across the cardiometabolic spectrum and reinforce our commitment to delivering options that meet patients' needs and preferences”
“The 12mg dose delivered a level of weight loss long associated with bariatric surgery.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.